WBA - Walgreens Boots Alliance, Inc.
NASDAQ
->
Healthcare
->
Pharmaceutical Retailers
Deerfield,
United States
Type: Equity
WBA price evolution
WBA
| (in millions $) | 1 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $703 | $668 | $784 | |
| Short term investments | ||||
| Net receivables | $5851 | $5949 | $6200 | $5972 |
| Inventory | $8320 | $8578 | $8557 | $9454 |
| Total current assets | $18335 | $16337 | $16561 | $17345 |
| Long term investments | $2961 | $3256 | $3400 | |
| Property, plant & equipment | $30107 | $30972 | $31463 | $32884 |
| Goodwill & intangible assets | $28657 | $28798 | $41462 | |
| Total noncurrent assets | $66648 | $67646 | $80478 | |
| Total investments | $2961 | $3256 | $3400 | |
| Total assets | $81037 | $82985 | $84207 | $97823 |
| Current liabilities | ||||
| Accounts payable | $14082 | $13100 | $12775 | $13593 |
| Deferred revenue | ||||
| Short long term debt | $3890 | $4276 | $4020 | |
| Total current liabilities | $26953 | $25034 | $24915 | $26116 |
| Long term debt | $8961 | $28786 | $29347 | $29717 |
| Total noncurrent liabilities | $42521 | $43928 | $43950 | |
| Total debt | $32676 | $33623 | $33737 | |
| Total liabilities | $70593 | $67555 | $68843 | $70066 |
| Shareholders' equity | ||||
| Retained earnings | $23348 | $26571 | $26448 | $32573 |
| Other shareholder equity | -$2899 | -$2894 | -$2897 | -$2995 |
| Total shareholder equity | $13642 | $13484 | $19481 | |
| (in millions $) | 1 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1358 | $1193 | ||
| Short term investments | $1114 | |||
| Net receivables | $5851 | $5381 | $5017 | $5663 |
| Inventory | $8320 | $8257 | $8353 | $8159 |
| Total current assets | $18335 | $15503 | $16902 | $15814 |
| Long term investments | $4236 | $5495 | $6987 | |
| Property, plant & equipment | $30107 | $33254 | $32988 | $34140 |
| Goodwill & intangible assets | $41822 | $33010 | $22357 | |
| Total noncurrent assets | $81125 | $73222 | $65471 | |
| Total investments | $4236 | $6609 | $6987 | |
| Total assets | $81037 | $96628 | $90124 | $81285 |
| Current liabilities | ||||
| Accounts payable | $14082 | $12635 | $11255 | $11136 |
| Deferred revenue | ||||
| Short long term debt | $3264 | $3345 | $3564 | |
| Total current liabilities | $26953 | $24535 | $22583 | $22054 |
| Long term debt | $8961 | $30269 | $32132 | $29828 |
| Total noncurrent liabilities | $43605 | $37134 | $35091 | |
| Total debt | $33533 | $35477 | $33392 | |
| Total liabilities | $70593 | $68140 | $59717 | $57145 |
| Shareholders' equity | ||||
| Retained earnings | $23348 | $33058 | $37801 | $35121 |
| Other shareholder equity | -$2899 | -$2993 | -$2805 | -$2109 |
| Total shareholder equity | $20020 | $25275 | $23419 | |
| (in millions $) | 1 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $37547 | $37052 | $36707 | |
| Cost of revenue | $30012 | $29937 | ||
| Gross Profit | $6253 | $7040 | $6770 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $7921 | $6851 | ||
| Total operating expenses | -$8163 | $20211 | $6809 | |
| Operating income | -$13171 | -$39 | ||
| Income from continuing operations | ||||
| EBIT | -$6552 | -$42 | ||
| Income tax expense | $2082 | -$782 | -$74 | |
| Interest expense | -$295 | $138 | $99 | |
| Net income | ||||
| Net income | -$3005 | -$5908 | -$67 | |
| Income (for common shares) | -$5908 | -$67 | ||
| (in millions $) | 1 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $147658 | $139081 | $132703 | $132509 |
| Cost of revenue | $112009 | $104437 | $104442 | |
| Gross Profit | $26524 | $27072 | $28266 | $28067 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $34205 | $27295 | $24586 | |
| Total operating expenses | $11291 | $33953 | $27295 | $25725 |
| Operating income | -$6881 | $971 | $2342 | |
| Income from continuing operations | ||||
| EBIT | -$4358 | $4707 | $4114 | |
| Income tax expense | $1246 | -$1858 | -$30 | $667 |
| Interest expense | -$1215 | $580 | $400 | $905 |
| Net income | ||||
| Net income | -$8636 | -$3080 | $4337 | $2542 |
| Income (for common shares) | -$3080 | $4337 | $2542 | |
| (in millions $) | 1 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $344 | -$5908 | -$67 | |
| Operating activities | ||||
| Depreciation | $607 | $614 | $616 | |
| Business acquisitions & disposals | $22 | -$119 | -$109 | |
| Stock-based compensation | $44 | $48 | $51 | |
| Total cash flows from operations | $604 | -$637 | -$281 | |
| Investing activities | ||||
| Capital expenditures | -$277 | -$352 | -$506 | |
| Investments | $46 | $300 | $427 | |
| Total cash flows from investing | $1878 | $204 | $817 | $85 |
| Financing activities | ||||
| Dividends paid | -$1260 | -$216 | -$413 | -$415 |
| Sale and purchase of stock | -$69 | |||
| Net borrowings | -$534 | $274 | $205 | |
| Total cash flows from financing | -$538 | -$785 | -$313 | $186 |
| Effect of exchange rate | $4 | $1 | $2 | |
| Change in cash and equivalents | $2362 | $25 | -$132 | -$10 |
| (in millions $) | 1 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$3080 | $4337 | $2542 | |
| Operating activities | ||||
| Depreciation | $2257 | $1990 | $1973 | |
| Business acquisitions & disposals | -$7313 | -$2189 | $4096 | |
| Stock-based compensation | $385 | $391 | $155 | |
| Total cash flows from operations | $2258 | $3899 | $5555 | |
| Investing activities | ||||
| Capital expenditures | -$2117 | -$1734 | -$1379 | |
| Investments | $1767 | $1308 | $856 | |
| Total cash flows from investing | $1878 | -$3094 | -$1064 | $4072 |
| Financing activities | ||||
| Dividends paid | -$1260 | -$1659 | -$1659 | -$1617 |
| Sale and purchase of stock | -$105 | -$160 | -$51 | |
| Net borrowings | -$2703 | $3587 | -$3440 | |
| Total cash flows from financing | -$538 | -$887 | -$1499 | -$9036 |
| Effect of exchange rate | $4 | $20 | -$47 | -$66 |
| Change in cash and equivalents | $2362 | -$1702 | $1288 | $525 |
News
Fundamentals
| Market cap | $8.88B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 864.00M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 6.00% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.68 |
| Quick ratio | 0.37 |